MedPage Today on MSN
FDA Approves First Farxiga Generics for Type 2 Diabetes
Generics gain indications for glycemic control, reducing heart failure hospitalization ...
Generic dapagliflozin is indicated to lower heart failure hospitalization risk in type 2 diabetes with established ...
The U.S. Food and Drug Administration (FDA) has approved a generic daily injectable for the GLP-1 medication for patients who are 10 years old and up with Type 2 diabetes. The liraglutide injection, ...
The FDA approved the first generic dapagliflozin tablets, opening a competitive US market for pharma manufacturers and ...
According to the Company, the generic product will launch immediately. The Food and Drug Administration (FDA) has approved Liraglutide Injection, the first generic version of Victoza ®. Liraglutide is ...
Multiple manufacturers receive FDA approval for generic dapagliflozin to treat type 2 diabetes and lower heart failure risks in high-risk T2D patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results